Epilepsy and Seizure Management

Epilepsy is a common and often challenging part of living with CLCN4-related neurodevelopmental disorder. While not every child with this condition will develop seizures, systematic research suggests that approximately 54.5% of individuals are affected ^[1]. Because these seizures can be complex, understanding the typical patterns and treatment options is essential for working with your child’s neurology team.

When Seizures Begin and What They Look Like

For most children with CLCN4-related epilepsy, seizures begin early in life. Research indicates that nearly 70% of those affected have their first seizure within their first year ^[1].

The disorder is known for causing multiple different seizure types in the same person ^[1]. Some of the most common include:

• Myoclonic Seizures: These are brief, shock-like jerks of a muscle or a group of muscles. They are the most frequently reported seizure type in this population ^[1].
• Focal Seizures: These begin in one specific area of the brain and can sometimes cause impaired consciousness or strange sensations ^[2].
• Generalized Tonic-Clonic Seizures: These involve a loss of consciousness and stiffening or jerking of the entire body ^[2].
• Absence Seizures: These can look like brief “staring spells” where the child is momentarily unresponsive.

Note on EEGs: There is no universally established schedule for screening EEGs. Routine EEGs do not replace clinical seizure observation, and a normal EEG does not exclude epilepsy. EEG decisions should be individualized based on events or specialist advice.

The Challenge of Drug-Resistant Epilepsy

Many families face drug-resistant epilepsy (also called refractory epilepsy), which means that seizures continue even after trying two or more appropriately chosen medications ^[1]. In some groups of patients, more than 60% of those with seizures were found to have this refractory form ^[3].

In severe cases, a child may be diagnosed with epileptic encephalopathy. This is a term used when the seizure activity itself—not just the underlying genetic change—contributes to further developmental delays or behavioral challenges ^[1].

Medical Management and Treatment Options

There is no single “magic” medication for CLCN4-related disorder, but some drugs have been reported to provide benefit in small groups of patients. These include lamotrigine, valproate, and levetiracetam ^[1][2]. Medication choice depends on seizure type, age, and comorbidities.

It is important to monitor for side effects: valproate carries liver, pancreas, and reproductive risks; lamotrigine carries a serious rash warning; and levetiracetam can cause behavioral effects. Never stop an antiseizure medication abruptly, as this can trigger severe seizures.

A Note on Benzodiazepines

Benzodiazepines (such as midazolam or diazepam) remain the standard first-line treatment for prolonged convulsive seizures. Parents should be aware that a single reported case described a child with a specific CLCN4 variant experiencing tonic status (a prolonged, stiffening seizure) after receiving benzodiazepines ^[4]. This is very limited, preliminary evidence and does not establish that benzodiazepines cause seizures in CLCN4 generally. You must follow your written Seizure Action Plan and never delay or withhold prescribed rescue treatment during a prolonged seizure based on this report. Discuss any concerns with your epileptologist at a routine visit.

Beyond Medications: Diet and Devices

When medications are not enough, other options may be explored at a comprehensive epilepsy center:

• Ketogenic Diet: This is a specialized high-fat, low-carbohydrate medical diet that must be managed by a specialist team. In the single case mentioned above, the ketogenic diet was used successfully ^[4]. This is a planned therapy, not an acute substitute for rescue treatment.
• Vagus Nerve Stimulation (VNS): This involves a small device implanted under the skin that sends regular pulses of electricity to the brain. It is an “adjunctive” or add-on treatment that may help reduce the frequency or severity of seizures when drugs fail ^[5].
• Epilepsy Surgery: In some cases of focal epilepsy, surgery to remove the specific area of the brain where seizures start may be considered. This requires a very detailed evaluation at a specialized epilepsy center ^[5][6].

Managing CLCN4-related epilepsy requires a long-term partnership with a specialized care team. Regular communication about any changes in your child’s seizure patterns is the best tool for finding the right treatment plan.